TRIPOD

(redirected from Troglitazone in the Prevention of Diabetes)
AcronymDefinition
TRIPODTroglitazone in the Prevention of Diabetes (clinical trial)
TRIPODTactical Reconstruction Information Pod
References in periodicals archive ?
In the Troglitazone in the Prevention of Diabetes (TRIPOD) study, 235 Hispanic women diagnosed with gestational diabetes during the previous 4 years were randomized to placebo or 400 mg troglitazone daily At 60 months, the number of patients with type 2 diabetes was 50% with placebo vs.